The value of palliative gastrectomy in gastric cancer with distant metastasis

Annals of Surgical Oncology

Volumn 19, Issue 4, 2012, Pages 1231-1239

  Chang, Ye Rim ^a   Han, Dong Seok ^a   Kong, Seong Ho ^a   Lee, Hyuk Joon ^a   Kim, Se Hyung ^a   Kim, Woo Ho ^a   Yang, Han Kwang ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; DOCETAXEL; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; PACLITAXEL;

ANASTOMOSIS STENOSIS; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; DISTANT METASTASIS; ELECTIVE SURGERY; FEMALE; GASTRECTOMY; GASTROJEJUNOSTOMY; HUMAN; LENGTH OF STAY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OVARY METASTASIS; PERITONEUM METASTASIS; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PROGNOSIS; RETROSPECTIVE STUDY; STOMACH CANCER; SURVIVAL RATE; SURVIVAL TIME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; FLUOROURACIL; GASTRECTOMY; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM SEEDING; NEOPLASM STAGING; OVARIAN NEOPLASMS; PALLIATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; RNA, TRANSFER, VAL; STOMACH NEOPLASMS;

EID: 84862506745     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2056-x     Document Type: Article

References (31)

1. Glimelius B, Hoffman K, Graf W, et al. Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol. 1995;6:267-74.
2. Murad AM, Santiago FF, Petroianu A, Rocha PR, Rodrigues MA, Rausch M. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer. 1993;72:37-41. (Pubitemid 23182046)
3. Pyrhonen S, Kuitunen T, Nyandoto P, Kouri M. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer. 1995;71:587-91.
4. Sarela AI, Yelluri S. Gastric adenocarcinoma with distant metastasis: is gastrectomy necessary? Arch Surg. 2007;142:143-9; discussion 9.
5. Wohrer SS, Raderer M, Hejna M. Palliative chemotherapy for advanced gastric cancer. Ann Oncol. 2004;15:1585-95. (Pubitemid 39567288)
6. Kikuchi S, Arai Y, Morise M, et al. Gastric cancer with metastases to the distant peritoneum: a 20-year surgical experience. Hepatogastroenterology. 1998;45:1183-8. (Pubitemid 28403315)
7. Samarasam I, Chandran BS, Sitaram V, Perakath B, Nair A, Mathew G. Palliative gastrectomy in advanced gastric cancer: is it worthwhile? ANZ J Surg. 2006;76:60-3.
8. Medina-Franco H, Contreras-Saldivar A, Ramos-De La Medina A, Palacios-Sanchez P, Cortes-Gonzalez R, Ugarte JA. Surgery for stage IV gastric cancer. Am J Surg. 2004;187:543-6. (Pubitemid 38373814)
9. Maekawa S, Saku M, Maehara Y, et al. Surgical treatment for advanced gastric cancer. Hepatogastroenterology. 1996;43:178-86. (Pubitemid 26083781)
10. Haugstvedt T, Viste A, Eide GE, Soreide O. The survival benefit of resection in patients with advanced stomach cancer: the Norwegian multicenter experience. Norwegian Stomach Cancer Trial. World J Surg. 1989;13:617-21; discussion 21-2.
11. Ouchi K, Sugawara T, Ono H, et al. Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol. 1998;69:41-4. (Pubitemid 28452272)
12. Hartgrink HH, Putter H, Klein Kranenbarg E, Bonenkamp JJ, van de Velde CJ. Value of palliative resection in gastric cancer. Br J Surg. 2002;89:1438-43.
13. Bonenkamp JJ, Sasako M, Hermans J, van de Velde CJ. Tumor load and surgical palliation in gastric cancer. Hepatogastroenterology. 2001;48:1219-21. (Pubitemid 33010395)
14. Doglietto GB, Pacelli F, Caprino P, Sgadari A, Crucitti F. Surgery: independent prognostic factor in curable and far advanced gastric cancer. World J Surg. 2000;24:459-63; discussion 64.
15. Gold JS, Jaques DP, Bentrem DJ, et al. Outcome of patients with known metastatic gastric cancer undergoing resection with therapeutic intent. Ann Surg Oncol. 2007;14:365-72. (Pubitemid 46175277)
16. Martin RC II, Jaques DP, Brennan MF, Karpeh M. Achieving RO resection for locally advanced gastric cancer: is it worth the risk of multiorgan resection? J Am Coll Surg. 2002;194:568-77. (Pubitemid 34496651)
17. D'Ugo D, Rausei S, Biondi A, Persiani R. Preoperative treatment and surgery in gastric cancer: friends or foes? Lancet Oncol. 2009;10:191-5.
18. Brenner B, Shah MA, Karpeh MS, et al. A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Ann Oncol. 2006;17:1404-11. (Pubitemid 44403435)
19. Schuhmacher C, Gretschel S, Lordick F, et al. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. J Clin Oncol. 2010;28:5210-8.
20. Loggie BW, Fleming RA, McQuellon RP, Russell GB, Geisinger KR. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg. 2000;66:561-8. (Pubitemid 30396247)
21. Rosen HR, Jatzko G, Repse S, et al. Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology. J Clin Oncol. 1998;16:2733-8. (Pubitemid 28363038)
22. Xu DZ, Zhan YQ, Sun XW, Cao SM, Geng QR. Meta-analysis of intraperitoneal chemotherapy for gastric cancer. World J Gastroenterol. 2004;10:2727-30.
23. Yan TD, Black D, Sugarbaker PH, et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol. 2007;14:2702-13. (Pubitemid 47460649)
24. Tsujimoto H, Ichikura T, Ono S, et al. Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer. Hepatol Int. 2010;4:406-13.
25. Okano K, Maeba T, Ishimura K, et al. Hepatic resection for metastatic tumors from gastric cancer. Ann Surg. 2002;235:86-91. (Pubitemid 34062403)
26. Sakamoto Y, Sano T, Shimada K, et al. Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol. 2007;95:534-9. (Pubitemid 47177216)
27. Chow LW, Lim BH, Leung SY, Branicki FJ, Gertsch P. Gastric carcinoma with synchronous liver metastases: palliative gastrectomy or not? Aust N Z J Surg. 1995;65:719-23.
28. Miyashiro I, Takachi K, Doki Y, et al. When is curative gastrectomy justified for gastric cancer with positive peritoneal lavage cytology but negative macroscopic peritoneal implant? World J Surg. 2005;29:1131-4. (Pubitemid 41618712)
29. Feussner H, Omote K, Fink U, Walker SJ, Siewert JR. Pretherapeutic laparoscopic staging in advanced gastric carcinoma. Endoscopy. 1999;31:342-7. (Pubitemid 29319800)
30. Selby PJ, Chapman JA, Etazadi-Amoli J, Dalley D, Boyd NF. The development of a method for assessing the quality of life of cancer patients. Br J Cancer. 1984;50:13-22. (Pubitemid 14092641)
31. Yasue M, Sakamoto J, Morimoto T, et al. Evaluation of the effect of pancreatic resection in advanced pancreatic cancer with special reference using hospital-free survival as a measure of quality of life. Jpn J Clin Oncol. 1995;25:37-45.